Pulmonary Carcinoid Surface Receptor Modulation Using Histone Deacetylase Inhibitors
Description:
Study describes the use of a non-cytotoxic dose of histone deacetylase (HDAC) inhibitors to induce pulmonary carcinoid somatostatin receptor subtype 2 (SSTR2) expression to diagnose pulmonary carcinoids.
Date:
June 3, 2019
Creator:
Guenter, Rachael E.; Aweda, Tolulope; Matos, Danilea M. Carmona; Whitt, Jason; Chang, Alexander W.; Cheng, Eric Y. et al.
Item Type:
Refine your search to only
Article
Partner:
UNT Health Science Center